The Europe fish vaccines market was valued at US$ 110.00 million in 2022 and is expected to reach US$ 191.33 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.
Surging Demand for Aquatic Animal-Derived Food Products Fuel the Europe Fish Vaccines Market
An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of negative health consequences. Thus, fish is highly advisable in diet for healthy growth and development as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet. Growing awareness regarding the nutritional benefits of fish consumption propels the demand for sustainable, high-quality, and healthy meat products. Therefore, the rising consumption of fish and fish-derived products fuels the fish vaccines market growth.
Europe Fish Vaccines Market Overview
The European fish vaccines market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the fish vaccines market. The European fish vaccines market is expected to witness significant growth during the forecast period due to factors such as the significant growth in aquaculture industry, surging demand for aquatic animal-derived food products, growing research and development activities for fish vaccines development by market players in the region. Aquaculture is one of the key food-production sectors in the UK. According to the Department of Business and Trade (UK), seafood purchase is estimated to be ~US$ 5.14 billion in Great Britain. According to Innovate UK, the production value of the aquaculture industry in the UK is ~US$ 730.88 annually. Various events are organized by regulatory authorities to increase the awareness regarding the importance of maintaining aquaculture and fisheries. In May 2023, the UK's largest trade show-Aquaculture UK-for the community of aquaculture was held in Aviemore, Scotland. This trade show focused on innovation and sustainability in fish health, cleaner fish breeding, genetic selection, and other topics.
Europe Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)
Europe Fish Vaccines Market Segmentation
The Europe fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.
Based on vaccine type, the Europe fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.
Based on application, the Europe fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.
Based on route of administration, the Europe fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.
Based on species, the Europe fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.
Based on country, the Europe fish vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe fish vaccines market share in 2022.
Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the Europe fish vaccines market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 110.00 Million |
| Market Size by 2030 | US$ 191.33 Million |
| CAGR (2022 - 2030) | 7.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Vaccine Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
1. Elanco Animal Health Inc
2. Hipra SA
3. Merck & Co Inc.
4. Phibro Animal Health Corp
5. Vaxxinova International BV
6. Zoetis Inc.
The Europe Fish Vaccines Market is valued at US$ 110.00 Million in 2022, it is projected to reach US$ 191.33 Million by 2030.
As per our report Europe Fish Vaccines Market, the market size is valued at US$ 110.00 Million in 2022, projecting it to reach US$ 191.33 Million by 2030. This translates to a CAGR of approximately 7.2% during the forecast period.
The Europe Fish Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Fish Vaccines Market report:
The Europe Fish Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Fish Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Fish Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)